BioCentury
ARTICLE | Company News

Harvard Scientific Corp, Biosphere Technologies Inc deal

April 15, 2013 7:00 AM UTC

HVSF acquired exclusive rights to Prostaglandin E-1 Lyophilized Liposomes to treat psoriasis from its parent company, Biosphere Technologies. (HVSF to start clinical trials, B11). ...